Biotechnology German Authority Gives Go Ahead To Novo Nordisk’s Small Bolt On Acquisition As Danish Firm Seeks To Build Heart Drugs Pipeline – Novo Nordisk (NYSE:NVO) Read more
Eurozone Novo Nordisk’s Popular Diabetes Drug Ozempic Starter Kits Face Extended Shortages in Germany, Faces Biosimilar Threat In China – Novo Nordisk (NYSE:NVO) Read more
Biotechnology How Much Does It Cost To Make Novo Nordisk’s Ozempic? Shockingly Low Against $1,000 Price Tag, Study Shows – Novo Nordisk (NYSE:NVO) Read more
Biotechnology Elevance, CVS Health Are First Medicare Insurers To Cover Novo Nordisk’s Weight Loss Sensation Wegovy – CVS Health (NYSE:CVS), Novo Nordisk (NYSE:NVO), Elevance Health (NYSE:ELV) Read more
Biotechnology Wegovy’s Success – Medicare Contemplates Covering Novo Nordisk’s Semaglutide For Heart Health – Novo Nordisk (NYSE:NVO) Read more
Biotechnology US Prescriptions Race For Weight Loss Drugs – Eli Lilly’s Zepbound Overtakes Novo Nordisk’s Wegovy – Eli Lilly and Co (NYSE:LLY) Read more
Biotechnology Inconsistent Insurance Coverage For Weight Loss Drugs – Novo Nordisk’s GLP-1s Face Hurdles Despite Health Benefits – Novo Nordisk (NYSE:NVO) Read more
Stockmarkets US FDA approves Novo Nordisk’s Wegovy for lowering heart risks Reuters via biedexmarkets.com Read more
Biotechnology Novo Nordisk’s Game-Changer: FDA Approves Weight Loss Sensation Wegovy For Heart Health, Potential Insurance Coverage – Novo Nordisk (NYSE:NVO) Read more
Biotechnology Novo Nordisk’s Stock Hits 52-Week High After Highly Sought After Obesity Drug Trial Data Why Novo Nordisk Stock Is Trading Higher Today – Novo Nordisk (NYSE:NVO) Read more
